Theresa Yeung

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

Theresa Yeung is an author at Peter MacCallum Cancer Centre specializing in metastatic castration-resistant prostate cancer, prostate cancer, and medicine.

Publications per year

2022–2023

Publications

AlphaBet: Combination of Radium-223 and [177Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol)

Louise Kostos, James P Buteau, Theresa Yeung et al. · Frontiers in Medicine · 2022 · 42 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

VIOLET: A phase I/II trial evaluation of radioligand treatment in men with metastatic castration-resistant prostate cancer with [<sup>161</sup>Tb]Tb-PSMA-I&T.

James P Buteau, Louise Kostos, Ramin Alipour et al. · Journal of Clinical Oncology · 2023 · 18 citations

Medicine, Oncology, Radiation Oncology +14

LuCAB: A phase I/II trial evaluating cabazitaxel in combination with [<sup>177</sup>Lu]Lu-PSMA-617 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Louise Kostos, James P Buteau, Grace Kong et al. · Journal of Clinical Oncology · 2023 · 11 citations

Medicine, Nuclear Medicine, Pharmacology +17

1–3 of 3